Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

Study ID: NCT05709912
Start Date: 2023-07-01
End Date: 2025-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

CARE Application

Usual Care

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

Study ID: NCT06855212
Start Date: 2025-02-26
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

21

Intervention / Treatment

Cemiplimab

Cetuximab

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma

Study ID: NCT06557512
Start Date: 2024-12-13
End Date: 2029-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

23

Intervention / Treatment

Hypofractionated Stereotactic Radiosurgery (SRS)

Magnetic Resonance Imaging (MRI)

Computed Tomography (CT)

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Digoxin Medulloblastoma Study

Study ID: NCT06701812
Start Date: 2025-07
End Date: 2027-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

23

Intervention / Treatment

Digoxin

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Study ID: NCT06640010
Start Date: 2025-01-13
End Date: 2026-12-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Non-Interventional Study

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Study ID: NCT03583710
Start Date: 2018-08-20
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

240

Intervention / Treatment

Cisplatin

Etoposide

Mitotane

Quality-of-Life Assessment

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Study ID: NCT02858310
Start Date: 2017-01-27
End Date: 2026-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

180

Intervention / Treatment

E7 TCR cells

Aldesleukin

Fludarabine

Cyclophosphamide

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Weight Loss Management in Endometrial Cancer Survivors

Study ID: NCT06877572
Start Date: 2025-03-25
End Date: 2030-10
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Weight loss with pharmacotherapy

Weight loss without pharmacotherapy

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Intraoperative OCT Guidance of Intraocular Surgery II

Study ID: NCT03713268
Start Date: 2018-09-30
End Date: 2026-05-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

262

Intervention / Treatment

Microscope integrated optical coherence tomography

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

Study ID: NCT02977468
Start Date: 2017-10-25
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

15

Intervention / Treatment

Merck 3475 Pembrolizumab

Intraoperative radiation therapy (IORT)

Sponsor

Eileen Connolly

Source: clinicaltrials.gov

Share:
Add to list